Natick-based Boston Scientific Corp. announced it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for two different lengths of its Promus Element stent, which is used to treat coronary artery disease patients.
As a result, 32 and 38-millimeter stents will be available in the United States immediately, the company said.
The stent system is now available in 94 sizes. The Promus is made from a proprietary alloy, which BSX says allows enhanced visibility, less recoil and higher radial strength.
